mHealth Intelligence October 9, 2017
Eric Wicklund

A committee of healthcare officials and FDA executives at Duke University has issued an action plan for incorporating consumer-facing mHealth data and devices into clinical trials.

A group of mHealth experts brought together by Duke University’s Duke-Margolis Center for Health Policy has drafted an action plan to integrate consumer-facing mHealth technology into clinical trials.

The 39-page plan, “Mobilizing mHealth Innovation for Real-World Evidence Generation,” examines the different types of data being generated by consumer-grade devices, such as wearables and apps, and offers five recommendations to make that data relevant to healthcare.

“There is not yet a clear path for how mHealth technologies can reliably and efficiently elicit, validate, and transmit relevant data, and such data are currently not being collected...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Analytics, Apps, Big Data, FDA, Health IT, mHealth, Patient / Consumer, Wearables
Lee Health to launch hospital-at-home program
Overweight, Obesity to Affect 64% of Americans by 2050
GLP-1 reduced heart failure risk by 46%: 8 study takeaways
Syndax Pharmaceuticals Leukemia Drug Wins a First-in-Class FDA Approval
Yale New Haven Health upgrades Epic

Share This Article